A H Ford

Summary

Affiliation: University of Western Australia
Country: Australia

Publications

  1. ncbi Homocysteine, grey matter and cognitive function in adults with cardiovascular disease
    Andrew H Ford
    Western Australian Centre for Health and Ageing, University of Western Australia, Perth, Western Australia, Australia
    PLoS ONE 7:e33345. 2012
  2. ncbi Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials
    Andrew H Ford
    WA Centre for Health and Ageing, Centre for Medical Research and School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, WA, Australia
    J Alzheimers Dis 29:133-49. 2012
  3. ncbi The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life
    Andrew H Ford
    Western Australian Centre for Health and Ageing, Centre for Medical Research, University of Western Australia, Perth, Australia
    Trials 11:8. 2010
  4. ncbi Vitamins B(12), B(6), and folic acid for cognition in older men
    A H Ford
    Centre for Medical Research and School of Psychiatry and Clinical Neurosciences, WA Centre for Health and Ageing, University of Western Australia, Perth, WA, Australia
    Neurology 75:1540-7. 2010
  5. ncbi Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia
    Andrew H Ford
    School of Psychiatry and Clinical Neurosciences M573, University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia
    J Neurol Neurosurg Psychiatry 83:70-5. 2012
  6. ncbi Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: the health in men study
    A H Ford
    WA Centre for Health and Ageing, Centre for Medical Research and School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, WA, Australia
    Mol Psychiatry 17:559-66. 2012

Detail Information

Publications6

  1. ncbi Homocysteine, grey matter and cognitive function in adults with cardiovascular disease
    Andrew H Ford
    Western Australian Centre for Health and Ageing, University of Western Australia, Perth, Western Australia, Australia
    PLoS ONE 7:e33345. 2012
    ..Elevated total plasma homocysteine (tHcy) has been associated with cognitive impairment, vascular disease and brain atrophy...
  2. ncbi Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials
    Andrew H Ford
    WA Centre for Health and Ageing, Centre for Medical Research and School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, WA, Australia
    J Alzheimers Dis 29:133-49. 2012
    ..It remains to be established if prolonged treatment with B-vitamins can reduce the risk of dementia in later life...
  3. ncbi The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life
    Andrew H Ford
    Western Australian Centre for Health and Ageing, Centre for Medical Research, University of Western Australia, Perth, Australia
    Trials 11:8. 2010
    ..We designed the B-VITAGE trial to determine whether adjunctive treatment with vitamins B6, B12 and folate increases the efficacy of standard antidepressant treatment...
  4. ncbi Vitamins B(12), B(6), and folic acid for cognition in older men
    A H Ford
    Centre for Medical Research and School of Psychiatry and Clinical Neurosciences, WA Centre for Health and Ageing, University of Western Australia, Perth, WA, Australia
    Neurology 75:1540-7. 2010
    ..To investigate whether supplementing older men with vitamins B(12), B(6), and folic acid improves cognitive function...
  5. ncbi Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia
    Andrew H Ford
    School of Psychiatry and Clinical Neurosciences M573, University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia
    J Neurol Neurosurg Psychiatry 83:70-5. 2012
    ..The authors designed this longitudinal study to determine if high tHcy and the MTHFR C677T polymorphism increase the risk of incident dementia among older men...
  6. ncbi Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: the health in men study
    A H Ford
    WA Centre for Health and Ageing, Centre for Medical Research and School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, WA, Australia
    Mol Psychiatry 17:559-66. 2012
    ..46, 95% CI 1.01-2.11, P=0.043). The results of this study are consistent with, but do not prove the hypothesis that high tHcy causes cognitive impairment in later life...